S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)

News crew guard dies after being shot in attempted robbery

Saturday, November 27, 2021 | Daisy Nguyen, Associated Press


This undated photo provided by the Town of Colma Police Department, in California, shows former Officer Kevin Nishita. Nishita, a retired police officer and armed guard who provided security for many reporters in the region, was shot in the abdomen during an attempted robbery of KRON-TV's camera equipment in Oakland, Calif., on Wednesday, Nov. 24, 2021. The news crew was covering a recent smash-and-grab robbery of a clothing store. Parts of California have been struck by a rash of organized retail thefts in which bands of thieves break into high-end stores and snatch merchandise. (Brandon Vaccaro/Colma Police Department via AP)

OAKLAND, Calif. (AP) — A security guard has died after he was shot while he protected a San Francisco Bay Area television news crew covering a smash-and-grab theft, part of a rash of organized retail crime in the region.

“We are devastated by the loss of security guard and our friend, Kevin Nishita. Our deepest sympathy goes to Kevin’s wife, his children, his family, and to all his friends and colleagues,” KRON-TV's vice president and general manager, Jim Rose, said in a statement issued Saturday.

Nishita was an armed guard for Star Protection Agency and provided security for television news crews in the region, who are often targeted by robbers for their equipment.

He was shot in the abdomen during an attempted robbery of KRON-TV's camera equipment near downtown Oakland on Wednesday, police said.

The news crew was covering a recent robbery where a group of thieves broke in and stole from a clothing store.

A reward of $32,500 is being offered for information that leads to an arrest in Nishita's killing.

Nishita was a police officer for the cities of Hayward, San Jose, Colma before retiring in 2018. The Alameda County Sheriff's office said deputies escorted his body from the hospital with full law enforcement honors.

“This senseless loss of life is due to yet another violent criminal act in the Bay Area. We hope that offering a reward will help lead to the arrest of those responsible so they can face justice for this terrible tragedy,” Rose said.

The region has been struck by organized retail thefts in which bands of thieves, some carrying crowbars and hammers, break into high-end stores and snatch merchandise.

Similar thefts have been reported in Los Angeles and Beverly Hills and elsewhere in the country.

At least eight thieves stormed a Home Depot store in Lakewood on Black Friday and grabbed hammers, crowbars and sledgehammers in the tool section before dashing off in a getaway vehicle, the Los Angeles County Sheriff’s Department said.

Four people who may have participated in the Home Depot theft were later arrested in Beverly Hills after officers stopped two cars that were part of a caravan of vehicles driving around the city's business district, police Lt. Giovanni Trejo said. A bystander called police after seeing that some of the vehicles did not display license plates, he said.

Meantime, police in Los Angeles arrested three people suspected of storming a designer clothing store on Melrose Place after stopping a vehicle and seeing clothes in plain view, said LAPD Officer Mike Lopez. He said more than 10 people ransacked another store on La Brea Avenue.

The thefts are believed to be part of sophisticated criminal networks that recruit people to steal merchandise in stores throughout the country and then sell it online. Experts and law enforcement officials say the thefts are ratcheting up as the holiday shopping season gets underway.

___

Associated Press radio reporter Julie Walker in New York contributed to this report.


7 Pharmaceutical Stocks to Buy For a Healthy Portfolio in 2022

One year ago, investors expected 2021 to be a huge year for pharmaceutical stocks. The bullish perspective was that as vaccines rolled out and the economy reopened, investors would shift from biotech stocks to traditional pharmaceutical stocks.

But the Delta variant has kept Covid-19 top of mind for many investors. While it’s true that some pharmaceutical stocks were part of the vaccine race, other players in the space have not performed as well as was hoped. Case in point, as of October 6, 2021, the iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is up only 9.7% in the last 12 months. And if you bought shares of the fund at the beginning of the year, you have no growth to show for your patience.

There are reasons beyond Covid-19 to consider when assessing the disappointing performance of pharmaceutical stocks. One is the current political climate which is making no secret of its desire to reshape the healthcare industry. And it has the pricing practices of “big pharma” firmly in its crosshairs.

However, the pharmaceutical sector is still loaded with quality stocks for investors who are willing to accept the inherent risk. And that’s the focus of this special presentation. In the next few minutes, we’ll take a look at seven pharmaceutical stocks that are ready to make strong moves forward in 2022.

View the "7 Pharmaceutical Stocks to Buy For a Healthy Portfolio in 2022".


Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.